FDA begins technology overhaul in preparation for tsunami of data and real-world evidence

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

To keep up with an increasingly data-rich health ecosystem, FDA is implementing a multi-year strategic plan to modernize its technology infrastructure—boosting cloud capabilities and building sophisticated data analytics for using real-world evidence to support regulatory decisions.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Matthew Bin Han Ong
Matthew Bin Han Ong
Table of Contents

YOU MAY BE INTERESTED IN

Patients treated with first-line immunotherapy for advanced non-small cell lung cancer showed similar results in terms of survival, progression-free survival, and treatment duration, regardless of race or ethnicity, even with differences in income and insurance, a study published in the Journal of the National Comprehensive Cancer Network showed.
Matthew Bin Han Ong
Matthew Bin Han Ong

Can you spare 10 minutes to complete a survey?

Your feedback is really important—you're helping us shape our coverage priorities and services to better serve you, our readers.

Login